Nature | Outlook
Nature Outlook: Bladder cancer
For three decades, the treatment of bladder cancer stood still. There were no new drugs and no improvements in diagnosis or survival rates. But all of that has changed, and now people with the disease and researchers have more options and hope. This Outlook discusses topics such as: how checkpoint-inhibitor drugs are helping those affected to survive for longer; why a healthy bladder is not sterile; and how the genetics of bladder cancer is revealing some surprising connections.
This Nature Outlook is editorially independent. It is produced with third party financial support. About this content.
Funded by a grant from: